scispace - formally typeset
K

Kim Burns

Researcher at University of Lausanne

Publications -  10
Citations -  7287

Kim Burns is an academic researcher from University of Lausanne. The author has contributed to research in topics: Signal transduction & FADD. The author has an hindex of 10, co-authored 10 publications receiving 7095 citations.

Papers
More filters
Journal ArticleDOI

Inhibition of death receptor signals by cellular FLIP

TL;DR: The characterization of an inhibitor of apoptosis is reported, designated FLIP (for FLICE-inhibitory protein), which is predominantly expressed in muscle and lymphoid tissues and may be implicated in tissue homeostasis as an important regulator of apoptotic regulation.
Journal ArticleDOI

Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors

TL;DR: A new family of viral inhibitors (v-FLIPs) which interfere with apoptosis signalled through death receptors3 and which are present in several γ-herpesviruses (including Kaposi's-sarcoma-associated human herpesvirus-8), as well as in the tumorigenic human molluscipoxvirus4.
Journal ArticleDOI

RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation.

TL;DR: This work investigated the 'downstream' signaling events that regulate TLR3-dependent Trif-induced NF-κB activation and found that RIP1 mediates Trif -RIP1–inducedNF-κBs activation.
Journal ArticleDOI

TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κB

TL;DR: It is shown that TRAil-R1 can associate with TRAIL-R2, suggesting that TRAIL may signal through heteroreceptor signaling complexes, and can signal both death and gene transcription, functions reminiscent of those of TNFR1 and TRAMP.
Journal ArticleDOI

The caspase-8 inhibitor FLIP promotes activation of NF-κB and Erk signaling pathways

TL;DR: Evidence is provided that FLIP is not simply an inhibitor of death-receptor-induced apoptosis but that it also mediates the activation of NF-kappaB and Erk by virtue of its capacity to recruit adaptor proteins involved in these signaling pathways.